MediLink Therapeutics: Focuses on ADC research and development to promote new prospects for cancer treatment


—– YL201 Phase I/II Investigators Meeting was successfully held in Guangzhou, China GUANGZHOU, China, Sept. 23, 2023 /PRNewswire/ — On September 23, 2023, oncologists and experts from more than 60 clinical research centers across the country gathered in Guangzhou to participate in the…

Leave a Reply